Oncolytics Biotech
ONCY
#9649
Rank
S$0.12 B
Marketcap
S$1.06
Share price
-0.97%
Change (1 day)
-33.04%
Change (1 year)

Oncolytics Biotech (ONCY) - Total debt

Total debt on the balance sheet as of March 2026 : S$0.65 Million

According to Oncolytics Biotech 's latest financial reports the company's total debt is S$0.65 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Oncolytics Biotech - Total debt on balance sheet (from 2000 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$0.72 M-30.12%
2024-12-31S$1.03 M145.63%
2023-12-31S$0.42 M14.3%
2022-12-31S$0.36 M-46.95%
2021-12-31S$0.69 M66.5%
2020-12-31S$0.41 M-20.17%
2019-12-31S$0.52 M
2018-12-31N/A
2006-12-31S$0.19 M-8.24%
2005-12-31S$0.21 M5.64%
2004-12-31S$0.2 M3.58%
2003-12-31S$0.19 M18.87%
2002-12-31S$0.16 M-5.22%
2001-12-31S$0.17 M0.61%
2000-12-31S$0.17 M0.54%
1999-12-31S$0.17 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eli Lilly
LLY
S$56.07 B 8,537,301.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$60.02 B 9,139,270.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
S$64.93 M 9,786.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$2.18 M 232.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$21.86 B 3,328,049.61%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
S$50.01 M 7,514.17%๐Ÿ‡บ๐Ÿ‡ธ USA